Phase II trial of liposomal daunorubicin in the treatment of AIDS- related pulmonary Kaposi's sarcoma

Journal of Clinical Oncology

Volumn 16, Issue 10, 1998, Pages 3369-3374

  Tulpule, Anil ^a   Yung, Rex C ^a   Wernz, James ^a   Espina, Byron M ^a   Myers, Adam ^a   Scadden, David T ^a   Cabriales, Suzanne ^a   Ilaw, Miki ^a   Boswell, William ^a   Gill, Parkash S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DAUNORUBICIN; ZIDOVUDINE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HELPER CELL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LUNG FUNCTION TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031727095     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.10.3369     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report. Atlanta, GA, CDC, February 1-23, 1993
2. Gill PS, Hamilton AW, Naidu Y: Epidemic (AIDS-related) Kaposi's sarcoma: Epidemiology, pathogenesis, and treatment. AIDS Updates 7:1-11, 1994
3. Ognibene, FP, Steis RG, Macher AM, et al: Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med 102:471-475, 1985
4. Meduri GU, Stover DE, Lee M, et al: Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome: Clinical, radiographic, and pathologic manifestations. Am J Med 81:11-18, 1986
5. Zibrak JD, Silvestri RC, Costello P, et al: Bronchoscopic and radiologie features of Kaposi's sarcoma involving the respiratory system. Chest 90:476-479, 1986
6. Garay SM, Belenko M, Fazzini E, et al: Pulmonary manifestations of Kaposi's sarcoma. Chest 91:39-43, 1987
7. Kaplan LD, Hopewell PC, Jaffe H, et al: Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. J AIDS 1:23-30, 1988
8. Gill PS, Akil B, Colletti P, et al: Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy. Am J Med 87:57-61, 1989
9. Hanson PJV, Harcourt-Webster JN, Gazzard BG, et al: Fibreoptic bronchoscopy in diagnosis of bronchopulmonary Kaposi's sarcoma. Thorax 42:269-271, 1987
10. Miller RF, Tomlinson MC, Cottrill CP, et al: Bronchopulmonary Kaposi's sarcoma in patients with AIDS. Thorax 47:721-725, 1992
11. Ireland-Gill A, Espina BM, Akil B, et al: Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin containing combination chemotherapy regimen. Semin Oncol 19:32-37, 1992
12. Laubenstein LJ, Kriegel RL, Odajnk CM, et al: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2:1115-1120. 1984
13. Gill PS, Rarick MU, McCutchan JA, et al: Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial. Am J Med 90:427-433, 1991
14. Saville MW, Lietzau J, Pluda JM, et al: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346:26-28, 1995
15. Gill PS, Espina BM, Muggia F, et al: Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 13:996-1003, 1995
16. Gill PS, Wernz J, Scadden DT, et al: Randomized phase III trial of liposomal daunorubicin (DaunoXome) versus doxorubicin, bleomycin, vincristine (ABV) in AIDS-related Kaposi's sarcoma. J Clin Oncol 14:2353-2364, 1996
17. Green S, Weiss GR: Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10:239-253, 1992
18. Krown SE, Metroka C, Wernz JC: Kaposi's sarcoma and the acquired immunodeficiency syndrome: A proposal for a uniform evaluation, response and staging criteria. J Clin Oncol 7:1201-1207, 1989
19. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
20. Mehta CR, Patel NR: A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 78:427-434, 1983
21. Tarone RE: Tests for trend in life table analysis. Biometrika 62:679-682, 1975
22. Presant CA, Scolaro M, Kennedy P, et al: Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet 341: 1242-1243, 1993
23. Bogner JR, Kronawitter U, Rolinski B, et al: Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi's sarcoma. J AIDS 7:463-468, 1994
24. Simpson JK, Miller RF, Spittle MF: Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma. Clin Oncol (R Coll Radiol) 5:372-374, 1993
25. O'Brien RF, Cohn DL: Serosanguinous pleural effusions in AIDS-associated Kaposi's sarcoma. Chest 96:460-466, 1989